
I’ve been watching the TSE governance reform story from Tokyo since the March 2023 disclosure mandate dropped, and what strikes me most is how differently the story reads when you pull the actual Japanese-language filings versus the headline summaries that reach English-language investors — the gap between “companies are complying” and “companies are genuinely changing” is wide, and that gap is where the investment edge lives right now.
Investment Thesis
Author’s View: Selective Constructive | Fair Value Estimate (Author’s Model): Thesis-based — Prime-listed industrials and financials crossing PBR 1.0x with rising ROE trajectory by FY2026 offer the clearest re-rating runway
Last updated: May 2025
- TSE’s March 2023 “comply-or-explain” mandate has triggered measurable buybacks, cross-shareholding unwinds, and capital-efficiency disclosures — but roughly 45-50% of Prime-listed companies still trade below PBR 1.0x as of early 2025, down from ~55% at reform launch.
- Aggregate TSE Prime buyback authorizations exceeded ¥17 trillion in FY2024; median ROE for Prime constituents rose from ~8% (FY2022) to an estimated ~10% (FY2024) — still well below MSCI World median of ~14%.
- Top risk: reform fatigue — companies filing boilerplate “plans” without specific ROE targets or accountability mechanisms, leaving PBR improvement cosmetic rather than structural.
Japan’s corporate governance reform cycle is entering a decisive phase. The Tokyo Stock Exchange’s 2023 ultimatum to sub-PBR-1.0x companies has produced a wave of disclosures, buybacks, and cross-shareholding sales that is genuinely moving aggregate metrics. But the English-language narrative — which tends to paint reform as either a sweeping success or a familiar disappointment — misses the granular, company-level reality visible only in Japanese-language filings. This article uses that primary-source data to answer the question US dividend and value investors actually need answered: is this reform cycle durable enough to drive a multi-year re-rating, or will it stall as previous governance pushes did?
Disclosure: This article is for informational purposes only and does not constitute investment advice. See full Disclaimer.
| Metric | FY2022 | FY2023 | FY2024E |
|---|---|---|---|
| TSE Prime Median ROE | ~8% | ~9% | ~10% |
| % Prime companies below PBR 1.0x | ~55% | ~50% | ~45-50% |
| Aggregate buyback authorizations (¥ trillion) | ~¥9t | ~¥13t | ¥17t+ |
| MSCI World Median ROE (reference) | ~14% | ~14% | ~14% |
| TSE Prime companies with explicit ROE targets (est.) | ~30% | ~45% | ~55% |
Why the TSE Drew a Line in the Sand on PBR 1.0x
From Abenomics to the 2023 Ultimatum — A Decade of Incremental Pressure
Japan’s governance reform story did not begin in 2023. The Abenomics-era Stewardship Code (2014) and Corporate Governance Code (2015) established the framework — independent directors, board diversity, shareholder engagement — but produced only modest ROE improvement at the aggregate level.
The JPX-Nikkei 400 index, launched in 2014, embedded ROE, operating profit, and governance scores as inclusion criteria, creating reputational pressure on exclusion. But inclusion mechanics are a blunt instrument — companies could optimize for index inclusion without genuinely improving capital efficiency.
By 2022, the Tokyo Stock Exchange had concluded that incremental pressure was insufficient. A majority of Prime Market companies still traded below book value — a structural anomaly that made Japan an outlier among developed markets and signaled to global allocators that Japanese management teams were not optimizing for shareholder returns.
What “Comply-or-Explain” Actually Requires (and What It Doesn’t)
In March 2023, the TSE issued a formal request to all Prime and Standard Market companies trading below PBR 1.0x — and to all companies regardless of PBR — to disclose their awareness of capital costs and concrete plans to improve capital efficiency. The request was framed as “comply-or-explain,” not binding regulation.
This distinction matters enormously. Companies are not legally required to hit ROE 10% or push PBR above 1.0x. They are required to acknowledge the problem and describe their response. The TSE tracks company responses on its public portal — the 「資本コストや株価を意識した経営の実現に向けた対応」フォローアップ page — publishing monthly updates on response rates by market segment.
This granular, company-level data is almost never cited in English-language coverage, which relies on aggregate response percentages. The TSE’s own tracking reveals not just who has responded, but the nature of those responses — a distinction that separates genuine reformers from box-checkers.
Why PBR 1.0x Became the Symbolic Threshold
PBR below 1.0x means the market values a company at less than its net assets — implying the market believes management will destroy, not create, value with those assets. For a developed-market exchange aspiring to global capital, this is an indictment.
The TSE’s choice of PBR 1.0x as the threshold was deliberate: it is simple, auditable, and internationally comparable. It also created a clear binary — above or below — that generates pressure without requiring regulators to define what “good” capital allocation looks like in each industry.
The TSE Market Restructuring Overview (Japanese) provides the full regulatory context for how this reform fits within the broader 2022 market segment reorganization that created the Prime, Standard, and Growth market tiers.
Scoreboard — ROE and PBR Progress Across TSE Prime
Sector Winners — Where ROE Improvement Is Real and Durable
The aggregate improvement in TSE Prime ROE from approximately 8% (FY2022) to an estimated 10% (FY2024) masks significant sector dispersion. Financials and trading companies (sogo shosha) have led the re-rating, driven by a combination of genuine operational improvement and balance sheet restructuring.
Major insurance groups — Tokio Marine, MS&AD, Sompo — have been among the most aggressive sellers of cross-shareholdings, redirecting released capital into buybacks and dividend increases. The megabanks (MUFG, SMFG, Mizuho) have similarly accelerated strategic equity sales under FSA pressure, with ROE trajectories visibly improving.
Trading companies present a more complex picture. Much of their ROE improvement reflects commodity cycle tailwinds and yen-denominated earnings translation gains — factors that may not persist. Investors should examine whether the DuPont drivers (net margin, asset turnover, leverage) show structural improvement or cyclical inflation.
Sector Laggards — Industries Where PBR Remains Structurally Depressed
Regional banks remain the most conspicuous laggard. Net interest margin compression under the BOJ’s prolonged near-zero rate environment structurally capped their ROE regardless of governance reform. While BOJ normalization provides some relief, regional banks face additional headwinds: loan growth constraints in declining-population prefectures and legacy IT infrastructure costs.
Regulated utilities face a different structural ceiling. Return on equity in regulated businesses is effectively capped by the rate-setting framework — governance reform cannot conjure returns that regulation does not permit. Investors should be cautious about expecting PBR re-rating in sectors where ROE improvement requires business model transformation, not just capital reallocation.
Individual company disclosures in EDINET (金融庁の電子開示システム) — specifically the capital cost and stock price policy sections embedded in 有価証券報告書 (annual securities reports) — reveal which companies have set explicit, numeric ROE targets versus vague aspirational language. This distinction is almost entirely absent from aggregated English-language reporting.
Reading the Buyback Data — Authorization vs. Actual Execution Gap
The ¥17 trillion+ in FY2024 buyback authorizations is a headline number that requires qualification. Authorization is not execution — companies announce buyback programs and then execute at varying rates depending on share price movements, cash flow, and management conviction.
Investors should focus on execution rates: what percentage of authorized buybacks were actually completed within the stated period? Companies with execution rates above 80% demonstrate genuine capital return commitment; those with rates below 50% may be using authorization announcements as a signaling tool without full follow-through.
TradingView’s historical chart view is a useful tool for cross-referencing buyback announcement dates against share price behavior — a pattern where price appreciation stalls immediately after announcement (suggesting limited actual buying) is a warning sign worth investigating in the underlying IR disclosures.
The Cross-Shareholding Unwind — Japan’s Slow-Motion Balance Sheet Revolution
Why Cross-Shareholdings Suppressed ROE for Decades
Strategic cross-shareholdings (政策保有株式) — where Company A holds shares in Company B as a relationship-maintenance mechanism, and vice versa — have been a defining feature of Japanese corporate balance sheets for decades. Estimates of total cross-shareholding value held by TSE Prime companies have historically ranged from ¥30 trillion to ¥50 trillion.
The ROE math is straightforward: equity deployed in low-yielding cross-shareholdings earns below the cost of capital, mechanically dragging down ROE. A company holding ¥500 billion in cross-shareholdings earning a 1-2% dividend yield is destroying value on that capital relative to its cost of equity — typically estimated at 7-9% for Japanese corporates.
The BOJ Financial System Report (日本銀行金融システムレポート) tracks cross-shareholding trends across the banking sector and provides quantitative data on the pace of unwind — data that is published in Japanese and rarely synthesized for international audiences.
Who Is Selling, Who Is Stalling — Sector-Level Unwind Rates
The FSA’s 2023 revised Corporate Governance Code language explicitly discourages cross-shareholdings without clear strategic rationale, and proxy advisors ISS and Glass Lewis have increasingly recommended votes against boards that retain large portfolios without credible reduction timelines.
Insurance companies have been the most aggressive sellers — Tokio Marine, MS&AD, and Sompo have each announced multi-year programs to reduce strategic equity holdings to near-zero. This is structurally significant: insurers were among the largest holders of cross-shareholdings, and their exit is releasing substantial capital.
The Toyota group cross-shareholding unwind has been a high-profile case study. Toyota Motor and its affiliated suppliers have been reducing mutual shareholdings, with Toyota announcing significant sales of holdings in group companies. The pace has been slower than activists prefer, but the direction is unambiguous.
The FSA Stewardship Code Expert Panel meeting minutes (スチュワードシップ・コードに関する有識者検討会) — published in Japanese on the FSA website — contain candid assessments of cross-shareholding reduction pace that are not summarized in English FSA press releases. These minutes are a primary source that rewards the effort of reading them in Japanese.
Where the Released Capital Is Going (and Whether It’s Enough)
Capital released from cross-shareholding sales is flowing primarily into buybacks and dividend increases — which is positive for shareholders but raises a second-order question: is the capital being redeployed into high-return business investment, or simply returned because management lacks higher-return opportunities?
For value investors, capital return is welcome regardless of the reason. But the long-term re-rating thesis requires that Japanese companies also improve operational returns — not just redistribute existing balance sheet inefficiency. This distinction drives the next section’s analysis.
Operational ROE vs. Financial Engineering — Separating Genuine Reform from Buyback Theater
DuPont Lens — Which ROE Drivers Are Sustainable?
The DuPont decomposition — ROE = Net Margin × Asset Turnover × Leverage — is the right analytical lens for evaluating whether Japan’s ROE improvement is durable. Improvement driven by net margin expansion and asset turnover improvement is structurally sustainable. Improvement driven primarily by leverage increases or one-time items is not.
At the TSE Prime aggregate level, the FY2022-FY2024 ROE improvement reflects a mix of all three drivers. Net margin improvement is real in manufacturing sectors that have benefited from yen-weakness-driven export competitiveness and pricing power recovery post-COVID supply chain normalization. Asset turnover improvement is more modest but visible in sectors that have restructured underperforming business units.
The risk is that yen-driven margin gains are partially cyclical. A yen strengthening scenario — plausible under BOJ normalization — would mechanically compress yen-denominated margins for exporters, potentially reversing a portion of the reported ROE improvement without any change in underlying business quality.
ROIC Disclosure as the Next Frontier Beyond ROE
METI’s 伊藤レポート2.0 (Ito Review 2.0) and the 価値協創ガイダンス2.0 (Value Co-Creation Guidance 2.0) — both published in Japanese by METI — provide the official framework Japanese companies are expected to use for capital efficiency disclosure. These documents are rarely read in full by English-language investors but contain the specific ROE and ROIC benchmarks against which companies are measured.
Return on Invested Capital (ROIC) is gaining traction as a more operationally meaningful metric than ROE, because it excludes financial leverage effects and focuses on the returns generated by the actual business. Companies that have moved to ROIC disclosure — and set explicit ROIC targets above their weighted average cost of capital — are demonstrating a more sophisticated understanding of value creation than those still focused solely on the 8% ROE threshold.
Investors can identify ROIC-disclosing companies through their 中期経営計画 (medium-term management plans), which are typically published in Japanese on company IR pages and filed through TDnet. Companies with ROIC targets embedded in their 中期経営計画 are generally ahead of the curve on capital discipline.
How GPIF and Domestic Institutions Are Raising the Bar
Japan’s Government Pension Investment Fund (GPIF), the world’s largest pension fund with approximately ¥220 trillion in assets, has been increasingly vocal about capital efficiency expectations. GPIF’s stewardship activity reports — published annually — detail engagement priorities that include ROE improvement, cross-shareholding reduction, and board independence.
When GPIF signals engagement priorities, domestic institutional investors (life insurers, trust banks managing pension mandates) tend to align their voting behavior accordingly. This creates a domestic institutional pressure layer that complements TSE regulatory pressure — and that is less visible to international investors than activist fund activity but arguably more impactful given the scale of domestic institutional ownership.
For US investors, the analogy is instructive: imagine if CalPERS, Vanguard, and BlackRock all simultaneously escalated governance engagement with S&P 500 companies on the same set of capital efficiency metrics. That is roughly the dynamic playing out in Japan’s institutional investor landscape right now.
2026 Catalysts — What Will Determine Whether Reform Sticks
TSE’s 2025-2026 Review — Carrots, Sticks, and the Demotion Threat
The TSE has signaled its intention to review compliance rates and potentially escalate consequences for non-responding companies through 2025-2026. The most credible stick is demotion from the Prime Market to the Standard Market — a consequence that would trigger exclusion from TOPIX and other Prime-linked passive benchmarks, forcing passive outflows.
The JPX-Nikkei 400 methodology already embeds ROE and governance criteria as inclusion factors — companies that fail to improve capital efficiency risk exclusion from this benchmark, which carries its own passive flow consequences. The combination of TSE demotion risk and JPX-Nikkei 400 exclusion risk creates a two-layer incentive structure for reform compliance.
The carrot side is equally important: companies that demonstrably cross PBR 1.0x with rising ROE trajectories become eligible for MSCI Japan rebalancing inflows as their market cap and liquidity metrics improve. The passive inflow tailwind from crossing key index thresholds can be substantial for mid-cap companies.
Activist Shareholders as Reform Accelerants — Japan’s New Normal
Foreign activist funds — Elliott Management, ValueAct Capital, Oasis Management, and others — have significantly increased their Japan presence over the past three years. Their activity is no longer exceptional; it is becoming normalized. Japanese companies that previously could rely on cross-shareholding allies to block activist proposals are finding those allies are now selling those shares.
The 2025-2026 AGM seasons will be a critical test. Proxy advisors ISS and Glass Lewis have both updated their Japan voting guidelines to recommend against director re-elections at companies with persistent PBR below 1.0x and no credible improvement plan. This creates a board accountability mechanism that did not exist five years ago.
BOJ Normalization — Tailwind or Headwind for Capital Reform?
BOJ rate normalization is a double-edged catalyst for the governance reform story. Higher rates benefit regional banks’ net interest margins — potentially improving ROE for one of the most persistent laggard sectors. But higher rates also increase the cost of capital for leveraged companies and may reduce the attractiveness of buyback-financed ROE improvement.
The yen dimension is equally important. A stronger yen under BOJ normalization would compress yen-denominated earnings for exporters, potentially reversing some of the FY2024 ROE gains that were partly driven by yen weakness. Investors should model both scenarios when evaluating exporter-heavy reform plays.
For US investors sizing positions in Japan equities, yen FX risk is a real consideration. An unhedged position in a Japanese exporter that benefits from yen weakness is simultaneously a long-JPY bet when viewed from a USD perspective — the equity gain from yen weakness may be partially offset by the FX translation loss when converting back to USD. IBKR’s currency conversion tools and Saxo Bank’s FX overlay options are worth exploring for investors with meaningful Japan allocations.
Risks and Counter-View — Why Reform Could Disappoint Again
Japan’s governance history offers several cautionary precedents, and investors who have followed this market through prior reform cycles are right to maintain healthy skepticism. Three structural risks deserve serious weight.
Reform fatigue and boilerplate compliance. A significant share of companies have submitted disclosure documents using templated language — acknowledging capital cost awareness without specific ROE targets, timelines, or accountability mechanisms. The TSE’s own disclosure tracking (available in Japanese at the TSE capital efficiency follow-up portal) shows that response rate is not the same as quality rate. A company that submits a two-page document stating “we are aware of our cost of capital and will strive to improve” has technically complied while committing to nothing measurable.
Structural ROE ceilings in certain sectors. Regional banks face NIM compression regardless of governance reform — their ROE ceiling is set by the interest rate environment and loan demand in their geographic markets, not by capital allocation decisions. Regulated utilities face return caps set by government rate-setting frameworks. Investors should not expect governance reform to produce ROE 10%+ in sectors where the business model structurally cannot support it.
Yen volatility masking underlying progress. Much of the FY2024 ROE improvement for TSE Prime exporters reflects yen weakness boosting yen-denominated earnings. The yen traded in a historically weak range through much of 2023-2024, providing a mechanical tailwind to reported earnings and ROE metrics. A sustained yen reversal — plausible under BOJ normalization — could reverse a portion of this improvement without any change in underlying business quality. English-language coverage has been insufficiently attentive to this FX distortion in the aggregate ROE data.
Political and regulatory risk. LDP leadership transitions and potential shifts in METI and FSA priorities could reduce the regulatory pressure that is currently driving corporate behavior. Japan’s governance reform momentum has historically been closely tied to political will at the top — a change in administration priorities could slow the pace of enforcement without formally reversing the policy framework.
Nikkei (日本経済新聞) and Toyo Keizai (東洋経済) publish annual corporate governance ranking surveys in Japanese that include qualitative assessments of disclosure quality — these rankings reveal which companies are gaming the system versus genuinely reforming, a distinction absent from English-language ESG scoring methodologies.
Bottom Line — How to Position Around Japan’s Governance Re-Rating
The reform is real, the direction is right, and the 2026 window matters — but the investment opportunity is not a broad Japan equity bet. It is a selective, company-specific play on the subset of Prime-listed companies where governance reform is translating into durable, operational ROE improvement rather than financial engineering.
The practical screen I apply: PBR in the 0.7x-1.2x range (enough upside, not a value trap), ROE trending toward 10%+ with DuPont drivers showing margin and turnover improvement (not just leverage), buyback execution rate above 80% of authorization, and cross-shareholding ratio declining year-over-year in the most recent 有価証券報告書.
Companies that meet this screen and have explicit, numeric ROE or ROIC targets embedded in their 中期経営計画 — with board accountability mechanisms tied to those targets — represent the highest-conviction subset of the Japan governance re-rating story.
Sectors to approach with caution: regional banks without clear rate normalization tailwinds, regulated utilities, and any company whose FY2024 ROE improvement is entirely explained by yen weakness rather than operational improvement. These are not necessarily bad businesses — but they are not governance reform plays.
For US investors building a Japan allocation, this reform cycle is most compelling as a complement to a dividend-focused strategy. Companies crossing PBR 1.0x with rising ROE tend to increase dividends and buybacks simultaneously — creating a total return profile that combines capital appreciation (re-rating) with growing income. That combination is rare in developed markets right now.
For specific names meeting this framework, cross-reference the individual stock analyses in this pillar: How U.S. Investors Can Target Sub-1× PBR Japan Stocks (2026) and Why U.S. Investors Need Japan’s 2.5% Yields (TSE 2026) — both provide company-level screening and analysis grounded in the same Japanese-language primary sources used here.
The 2026 window is not infinite. TSE review pressure, AGM season proxy dynamics, and potential MSCI rebalancing inflows create a 12-18 month period where reform-compliant companies may see accelerated re-rating. Investors who wait for the English-language narrative to fully catch up will likely find the easy money already made.
Frequently Asked Questions
Q: What does PBR governance pressure actually mean for a US investor?
PBR (Price-to-Book Ratio) governance pressure refers to the TSE’s mandate that companies trading below 1.0x book value — meaning the market values them at less than their net assets — must disclose plans to improve capital efficiency. For US investors, the analogy is if the NYSE required every S&P 500 company trading below book value to publish a detailed capital return plan or face demotion to a lower market tier. The practical effect is pressure on Japanese management teams to increase buybacks, cut cross-shareholdings, raise dividends, and improve ROE — all of which are positive for shareholders.
Q: How does Japanese dividend withholding tax work for US investors?
Japanese dividends are subject to a 20.315% withholding tax at source. Under the US-Japan tax treaty, this is reduced to 15% for eligible US investors. The withheld amount is claimable as a foreign tax credit on IRS Form 1116, effectively reducing your US tax liability by the amount withheld. For IRA accounts, foreign tax credits cannot be claimed, so the 15% withholding is a permanent cost — factor this into your yield calculation when comparing Japan dividend stocks to US equivalents.
Q: Can I screen for TSE Prime governance reform plays using standard US brokerage tools?
Standard US brokerage screeners (Fidelity, Schwab) have limited Japan-specific data. For PBR and ROE screening of TSE Prime stocks, TradingView’s screener provides reasonable coverage with filters for P/B ratio and ROE. For deeper analysis — including cross-shareholding ratios and 中期経営計画 targets — you will need to access EDINET (edinet-fsa.go.jp) directly for Japanese-language filings. IBKR’s Fundamentals Explorer also provides TSE stock data that is more comprehensive than most US retail platforms.
Q: Is this reform different from the Abenomics governance push that didn’t move the needle much?
There are meaningful differences this time. The 2014-2015 Stewardship and Corporate Governance Codes were aspirational frameworks with limited enforcement mechanisms. The 2023 TSE mandate is tied to concrete market structure consequences — potential demotion from Prime Market, which triggers TOPIX exclusion and passive outflows. Additionally, the cross-shareholding unwind is now accelerating under FSA pressure and proxy advisor voting guidelines, removing the defensive shareholder base that previously allowed management to ignore activist pressure. The reform is not guaranteed to succeed, but the structural incentives are more aligned than in the Abenomics era.
Q: What is the best way to get exposure to the Japan governance re-rating theme from a US brokerage account?
US investors have several options. Direct TSE stock purchases are available through IBKR and Saxo Bank with competitive JPY/USD spreads. For broad exposure, ETFs like the iShares MSCI Japan ETF (EWJ) or the WisdomTree Japan Hedged Equity Fund (DXJ, which hedges yen risk) provide diversified access. For a more targeted governance-reform play, individual stock selection using the PBR/ROE/buyback execution screen described in this article — accessible via IBKR’s direct TSE access — offers the highest potential alpha but requires more research effort. The ETF route sacrifices the company-specific upside but eliminates single-stock and yen risk.
How to Access Japan Governance Reform Stocks as an International Investor
The stocks discussed in this governance reform framework trade on the Tokyo Stock Exchange Prime Market. There are no single ADR programs for the broad TSE Prime universe — investors seeking company-specific exposure need direct TSE access or ETF vehicles.
International investors can access TSE Prime stocks directly through:
- Saxo Bank — full TSE coverage, available in Singapore, Japan, Europe, and most countries. Strong platform for Japan equity access. Preferred broker for our Singapore/Asia-based readers.
- Interactive Brokers (IBKR) — direct TSE access, competitive JPY/USD spread, available in US and most countries. Strong choice for US-based investors seeking individual TSE Prime stock exposure.
- Webull — lower minimums, growing TSE coverage, good for smaller position sizes (US audience).
Tax notes by country:
- Singapore: No capital gains tax on Japan stocks. Japanese dividends are subject to 20.315% withholding (15% when the Japan-Singapore tax treaty applies via your broker). Net dividend received after withholding — check with your broker on treaty reclaim procedures.
- United States: Japanese dividend withholding is 15% under the US-Japan tax treaty; claimable as a foreign tax credit on IRS Form 1116. IRA holders cannot claim the foreign tax credit — factor the 15% withholding as a permanent yield drag in tax-advantaged accounts.
- Other countries: Withholding rates vary by treaty. Check Japan’s National Tax Agency treaty list or consult your broker.
Account opening eligibility varies by country of residence. I am not affiliated with these brokers; this is general information only. Always verify current terms directly with the broker.
This article is published under FTC 16 CFR Part 255 disclosure requirements. Opinions expressed are my own and do not constitute investment advice — they reflect my personal analytical view as a Tokyo-based investor following Japanese equities. I may or may not hold positions in individual TSE Prime stocks discussed in this framework analysis. All data cited reflects publicly available sources as of May 2025. Market conditions, TSE policy, and company disclosures change — verify current figures before making any investment decision. For full terms, see the Disclaimer.